Harbour BioMed presents HBICE Platform, an HCAb Based Immune Cell Engager

China |  News | 0 Comment | 01 Sep, 2020

Harbour BioMed, a global, clinical-stage, innovative biopharmaceutical company, has launched its newly developed HBICETM...Read more

"6th Annual Biopharma Development and Production Week" set to go virtual

China |  News | 0 Comment | 01 Sep, 2020

"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th Novem...Read more

BeiGene signs licensing agreement with Singlomics for COVID-19 Abs

China |  News | 0 Comment | 02 Sep, 2020

The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...Read more

Hong Kong study reveals testicular pain may be caused by spinal disease

China |  News | 0 Comment | 01 Sep, 2020

Hong Kong recorded that about 4.8% of men visited their urologist with chronic testicular pain. A new study, led by ...Read more

CStone receives US FDA IND clearance to evaluate Sugemalimab Monotherapy

China |  News | 0 Comment | 31 Aug, 2020

CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...Read more

Prudential and Huami expand partnership to deliver new health products

China |  News | 0 Comment | 31 Aug, 2020

China-based Huami Corp. and Huami-USA (HMI), a healthcare services company whose mission is to connect health with ...Read more

HJB & Ansun enter into strategic agreement for CMC development

China |  News | 0 Comment | 28 Aug, 2020

China-based HJB, a biologics Contract Development and Manufacturing Organization (CDMO) committed to quality, reliabilit...Read more

Sihuan Pharma launched Equity Incentive Plan to inject new impetus

China |  News | 0 Comment | 27 Aug, 2020

Hong Kong-based Sihuan Pharmaceutical Holdings Group Ltd. announced that on 26 August 2020, the Company granted a t...Read more

Graft versus host disease market to grow at 8.2% CAGR across 5 APAC markets in 10 years

China |  News | 0 Comment | 27 Aug, 2020

The market for graft versus host disease (GvHD) prophylaxis and treatment in the five growth markets (5GM*) in the Asia-...Read more

HKBN unveils UV-C disinfection to fight COVID-19

China |  News | 0 Comment | 27 Aug, 2020

HKBN Enterprise Solutions has announced the launch of innovative, one-stop disinfection solutions to help companies main...Read more

Sinovac inks new agreements for COVID-19 vaccine cooperation

China |  News | 0 Comment | 26 Aug, 2020

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced it has signed two agreeme...Read more

The 4th Shizhu health and wellness conference opens in China

China |  News | 0 Comment | 25 Aug, 2020

The 4th China Chongqing (Shizhu) health and wellness conference opened on Aug 22 in Huangshui Town, Shizhu County. At th...Read more

Thermo Fisher inks CDx agreement with Hengrui Therapeutics

China |  News | 0 Comment | 24 Aug, 2020

Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Hengrui Therapeutics, Inc. (HTI), a US s...Read more

Ascletis completes bridging study of ASC18

China |  News | 0 Comment | 21 Aug, 2020

China-based Ascletis Pharma Inc. recently announced that it completed bridging study of ASC18, the first one-pill, ...Read more

Mindray sets new standard for infusion systems

China |  News | 0 Comment | 20 Aug, 2020

China based Mindray, a leading provider of medical devices and solutions, has released its new generation infusion syste...Read more

Hua Medicine, Bayer bring novel diabetes treatment in China

China |  News | 1 Comment | 19 Aug, 2020

Bayer and Hua Medicine, a leading innovative drug development company, have announced a commercialization agreement and ...Read more

NMPA approves China's first trastuzumab biosimilar

China |  News | 0 Comment | 18 Aug, 2020

  Shanghai-based Henlius Biotech, Inc. (HK) recently announced that the trastuzumab biosimilar HLX02, develop...Read more

HiFiBiO collaborates with coronavirus immunotherapy consortium

China |  News | 0 Comment | 18 Aug, 2020

HiFiBiO Therapeutics, a multinational biotherapeutics company focused on the development of novel antibodies for immunom...Read more